Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation
Authors:
- Sho-Ichi YamagishiSYSho-Ichi Yamagishi
- 1 July 2009
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 385 (2) , 269-272
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 12 references indexed in Scilit:
- Intervention with cilostazol attenuates renal inflammation in streptozotocin-induced diabetic ratsLife Sciences, 2008
- Role of Oxidative Stress in the Development of Vascular Injury and its Therapeutic Intervention by NifedipineCurrent Medicinal Chemistry, 2008
- Kinetics, Role and Therapeutic Implications of Endogenous Soluble form of Receptor for Advanced Glycation end Products (sRAGE) in DiabetesCurrent Drug Targets, 2007
- Molecular Mechanisms of Diabetic Nephropathy and Its Therapeutic InterventionCurrent Drug Targets, 2007
- Optimal control of blood pressure in patients with diabetes reduces the incidence of macro and microvascular eventsJournal Of Hypertension, 2007
- Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activationDiabetologia, 2006
- Pigment Epithelium-derived Factor Inhibits Advanced Glycation End Product-induced Retinal Vascular Hyperpermeability by Blocking Reactive Oxygen Species-mediated Vascular Endothelial Growth Factor ExpressionJournal of Biological Chemistry, 2006
- Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated miceKidney International, 2006
- Diabetic Vascular Complications: Pathophysiology, Biochemical Basis and Potential Therapeutic StrategyCurrent Pharmaceutical Design, 2005
- Thiazolidinediones Reduce Endothelial Expression of Receptors for Advanced Glycation End ProductsDiabetes, 2004